Elranatamab in relapsed or refractory multiple myeloma: phase 2 MagnetisMM-3 trial results
Elranatamab治疗复发或难治性多发性骨髓瘤:MagnetisMM-3 II期试验结果
期刊:Nature Medicine
影响因子:50
doi:10.1038/s41591-023-02528-9
Lesokhin, Alexander M; Tomasson, Michael H; Arnulf, Bertrand; Bahlis, Nizar J; Miles Prince, H; Niesvizky, Ruben; Rodrίguez-Otero, Paula; Martinez-Lopez, Joaquin; Koehne, Guenther; Touzeau, Cyrille; Jethava, Yogesh; Quach, Hang; Depaus, Julien; Yokoyama, Hisayuki; Gabayan, Afshin Eli; Stevens, Don A; Nooka, Ajay K; Manier, Salomon; Raje, Noopur; Iida, Shinsuke; Raab, Marc-Steffen; Searle, Emma; Leip, Eric; Sullivan, Sharon T; Conte, Umberto; Elmeliegy, Mohamed; Czibere, Akos; Viqueira, Andrea; Mohty, Mohamad